ASX - Delayed Quote AUD

Neuren Pharmaceuticals Limited (NEU.AX)

Compare
13.40 -0.04 (-0.33%)
As of 11:14:49 AM GMT+11. Market Open.

Environment, Social and Governance (ESG) Risk Ratings

Total ESG Risk Score

34.1

Severe

ESG Risk Score for Peers

NameTotal ESG Risk scoreESG
PHAT Phathom Pharmaceuticals, Inc. 34 -- -- --
30J.SG Ideaya Biosciences Inc. 34 -- -- --
NEU.AX NEUREN FPO NZ [NEU] 34 -- -- --
5IU.MU Isofol Medical AB N 34 -- -- --
AMLX Amylyx Pharmaceuticals, Inc. 34 -- -- --

Controversy Level

ESG data provided by Sustainalytics, Inc. Last Updated on 12/2024
NEU.AX
Category Average
N/A None Controversy Level
None 4 Severe

Product Involvement Areas

Products and Activities Significant Involvement
Alcoholic Beverages No
Adult Entertainment No
Gambling No
Tobacco Products No
Animal Testing Yes
Fur and Specialty Leather No
Controversial Weapons No
Small Arms No
Catholic Values No
GMO No
Military Contracting No
Pesticides No
Thermal Coal No
Palm Oil No

Related Tickers